DONATE TODAY
To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

June 2, 2023

EBCI To Attend ASCO 2023

EBCI logo white


Visit Us at Booth #3005!

ASCO 2023 banner
Photo of ASCO meeting

EBCI ATTENDING  #ASCO23

June 2nd - 6th, 2023 Booth #3005

Why are we attending ASCO?

EBCI focuses on brain disease education, outreach, and awareness to this patient community and their families...worldwide; as well as to the general public; about treatments, studies, clinical trials, devices, diagnostics, genomic testing etc. One of the primary platforms used to deliver this disease education is via our digital footprint; thanks to our accomplished social/digital team. In 2020 our outbound education and communications resulted in a total of over 18 million opportunities for brain tumor disease awareness, education and outreach. With the development of our new APP in 2022, our Outreach via social media, e-newsletters, website, blogs, online support groups, online forums and in conjunction with our existing distribution partnerships via CURE MagazineMJH Life Sciences Publishing and Cox Media; we expect this number to exponentially increase. 

Would you like to partner with The EndBrainCancer Initiative (EBCI)? Our team will be at ASCO through the 6th of June. If you'd like to meet to discuss potential partnership opportunities for your company, please contact our founder, Dellann Elliott Mydland, directly at 425-785-8489 or dellann@endbraincancer.org.

ENDBRAINCANCER INITIATIVE | CHRIS ELLIOTT FUND

Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
DONATE
corporate partners
upcoming events
resources
About us
envelopephonemap-markerpointer-right
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram